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Dicarboxylic acids, thiosemicarbazides and methylanthranilate were reacted to give methyl-2-(3-(5-mercapto-4-s-1,2,4-
triazol-3-yl)-3-oxoalkylamino)benzoates 4. The latters, have been cyclized with hydrazine hydrate to give 3-amino-2-((5-
mercapto-4-substitued 1,2,4-triazol-3-yl)alkyl)quinazolin-4(3H)-ones 5 which expected to have biological effects. 
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INTRODUCTION:  
Attention has been increasingly paid to the synthesis of bis-heterocyclic compounds, which exhibit various biological 
activities more than heterocyclic ones. These activities include antibacterial, fungicidal, tuberculostatic and plant growth 
regulative properties [1-6]. Also, it has been indicated in several reports that biquinazolinones have a wide range of 
applications in synthesis and as chiral building blocks [7, 8]. 4(3H)-Quinazolinones are known for more than a century [9]. 
Molecules based on quinazoline and quinazolinone exhibit multitude of interesting pharmacological activities [10], 
including anticonvulsant, antibacterial and antidiabetic activity [11, 12]. The important natural and synthetic 4(3H)-
quinazolinones include l-vasicinone [13], chrysogine [14], methaquinolin [15], a sedative piriqualone [16-18], Febrifugine 
and iso febrifugine which possess this ring system were known as potent but toxic antimalarial agents long for than initial 
isolation [19] and recent chemical studies [20-23]. On the other hand, 1,2,4-triazole derivatives may exhibit different 
pharmacological activities such as anti-inflammatory, anti-fungal, anti-bacterial, and anti-viral. Some other 1,2,4-triazole 
derivatives have been reported to possess tuberculostatic, herbicidal and plant growth regulator activities [24-27]. In view 
of this the chemistry of bis-quinazolinones [28-31], and bis-4-amino-s-triazoles [32,33] was judicious to investigate the 
synthesis of asymmetric bis-heterocyclic compounds which have been unreported hitherto and are expected to possess 
biological activity [34-37].    
RESULTS AND DISCUSSION:  
Various new types of bis-heterocycles are having both 3-aminoquinazolinone and 1,2,4-triazole moieties were established 
through the synthesis of these research work via different routes. In the first route, the synthesis of 3-amino-2-((5-
mercapto-4 substitued-1,2,4-triazol-3-yl)alkyl)quinazolin-4(3H)-ones 5a-j took place via two steps: Firstly, the one pot 
reaction of thicarbohydrazide 1a,b, the dicarboxlic acid 2, and  methylanthranilate 3 under fusion conditions afforded  the 
corresponding methyl-2-(3-(5-mercapto-4-substitued-1,2,4-triazol-3-yl)-3-oxoalkylamino)benzoates 4a-j. Secondly, 
refluxing of the mono amide intermediates 4a-j with excess amount of hydrazine hydrate in n-butanol for 3-5 hours gave 
the target compound 5a-j in a good yield. In the second route, the dicarboxylic acids 2 were refluxed with methyl 
anthranalate 3 in absolute ethanol to give methyl anthraniloyl mono carboxylates 6a-e analogously, interaction of 6a-e with 
thiocarbhydrazides 1a,b under fusion conditions to give the corresponding mono amides 4a-j which refluxed with 
hydrazine hydrate to afford 5a-j. In the third route, the dicarboxylic acids 2 were refluxed with thiocarbhydrazides 1a,b in 
absolute ethanol to give substituted-(4-methylthiosemicarbazido)-3-oxocarboxylic acids 7a-j was interacted with methyl 
anthranalate 3 under fusion conditions to give the corresponding mono amides 4a-j. The latters were refluxed with 
hydrazine hydrate to afford 5a-j as mentioned above. Characterization of the newly synthesized compounds was 
elucidated owing to their spectral data IR, mass and 
1
H NMR in addition to elemental analysis. (Scheme 1) 
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In the fourth route, substituted-(4-methylthiosemicarbazido)-3-oxocarboxylic acids 7e-h could be obtained from boiling of 
dicarboxylic acid anhydrides 8a,b with thiocarbhydrazides 1a,b. The fusion of 7e-h with methyl anthranalate 3 gave 2-(3-
(5-mercapto-4-substitued-1,2,4-triazol-3-yl)-3-oxoalkylamino)benzoates 4e-h. Finally, dicarboxylic acid anhydrides 8a,b 
were refluxed with methyl anthranalate 3 to afford methyl anthraniloyl mono carboxylates 6c,d which gave 3-(3,4-dihydro-














































                                                                                 ISSN 2321-807X 
3111 | P a g e                                                    N o v e m b e r  1 6 ,  2 0 1 4 
EXPERIMENTAL  
All melting points were uncorrected. IR spectra were recorded (KBr disc) on a Shimadzu FT-IR 8201 PC 
Spectrophotometer.
 1
H-NMR spectra were recorded in CDCl3 or (CD3)3SO on a Varian Gemini 200 MHz Spectrometer and 
chemical shifts were expressed in units using TMS as an internal reference. Elemental analyses were carried out at the 
Microanalytical Center, Cairo University, Giza, Egypt, and National Research Centre. 
Methyl-2-(3-(5-mercapto-4-s-1,2,4-triazol-3-yl)-3-oxoalkylamino) benzoates 4a-j:  
Method (A): A mixture of semicarbazide or thiocarbohydrazide(0.005 mol) 1a,b, dicarboxylic acids 2 (0.01 mol) and 
methylanthranilate 3 (0.005 mol)  was heated in an oil bath at 170 
0
C for 30 min., the resulting solid was collected and 
recrystallized from ethanol to give the respective amides 4a-j. 
Method (B): The semicarbazide or thiocarbohydrazide(0.01 mol) and mono amides 6a-e (0.01 mol),were heated in an oil 
bath at 170 
0
C for 30 min. the resulting solid was collected and recrystallized from ethanol to give the respective amides 
4a-j. 
Method (C): The carboxylic acid derivatives 7a-j (0.01 mol) and methylanthranilate (0.01 mol)  were heated in an oil bath 
at 170 
0
C for 30 min. the resulting solid was collected and recrystallized from ethanol to give the respective amides 4a-j. 
3-Amino-2-[3-(4-amino-5-mercapto-4H-[1,2,4]traizol-3-yl)-alkyl]-3H-quinazolin-4-ones (5a-j): 
The corresponding amides 4a-j (0.01 mol) and 95% hydrazine hydrate (0.05 mol) were dissolved in n- butanol (30 ml) and 
refluxed for 6-8 hours. Cooling the reaction mixture in ice gave the crude product, which was filtered off and recrystallized 
to give compounds 5a-j. 
Methyl anthraniloyl mono carboxylates (6): 
Method (A):  
A mixture of the dicarboxylic acids 2 (0.01 mol) and methylanthranilate 3 (0.01 mol) was dissolved in ethanol and refluxed 
for 3-4 hours. After cooling, the precipitate so formed was filtered and recrystallized from the appropriate solvent to give 
6a-e. 
Method (B):  
A mixture of the acid anhydride 8a,b (0.01 mol) and methylanthranilate 3 (0.01 mol) was dissolved in ethanol and refluxed 
for 3-4 hours. After cooling the precipitate so formed was filtered and recrystallized from the appropriate solvent to give 
6c,d. 
Substituted-(4-methylthiosemicarbazido)-3-oxocarboxylic acids (7):  
Method (A):  
A mixture of the dicarboxylic acids 2 (0.01 mol) and semicarbazide or thiocarbohydrazide(0.01 mol),was dissolved in 
ethanol (30 ml) and refluxed for 4-5 hours. After cooling, the precipitate so formed was filtered and recrystallized from the 
appropriate solvent to give 7a-j. 
Method (B):  
A mixture of the acid anhydride 8a,b  (0.01 mol) and semicarbazide or thiocarbohydrazide(0.01 mol),was dissolved in 
ethanol (30 ml) and refluxed for 4-5 hours. After cooling, the precipitate so formed was filtered and recrystallized from the 
appropriate solvent to give 7e-h. 
3-(3,4-dihydro-3-amino-4-oxoquinazolin-2-yl)alkanehydrazides (9a,b): 
The corresponding amides 6a,b (0.01 mol) and 95% hydrazine hydrate (0.05 mol) were dissolved in n- butanol (30 ml) and 
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Table 1: Characterization Data of the Newly Synthesized Compounds 
 
Elemental analysis 
calcd. / found% 
 
Mol. Formula 
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Table 2: Spectral Data of Some Newly Synthesized Compounds: 
Comp. no Spectral data 
4f IR ύ (cm
-1
): 3273, 3161 (NH2); 1655 (C=O); 1621 (C=N) and 1600 (C=C). 
4h IR ύ (cm
-1
): 3277, 3219 (NH2) 1651 (C=O); 1625 (C=N) and 1601 (C=C). 
Mass (m/z): 335 (100%); 336 (17.0%) and 337 (5.0 %). 
4g Mass (m/z): 320 (100 %); 321 (3.0 %) and 322 (2.0 %). 
5b Mass (m/z): 275 (100 %); 276 (12.0 %) and 277 (3.0 %). 
5f IR ύ (cm
-1
): 3239, 3123 (NH2) 1654 (C=O); 1613 (C=N) and 1602 (C=C). 
1
H NMR δH (ppm): 3.08-3.49 (m, 4H, CH-aliph.); 5.80-5.64 (s, 4H, 2NH2); 8.16-7.50 (m, 
4H, ArH's) and 13.48 (s, 1H, NH) 
Mass (m/z): 303 (100%); 287 (53%), 243 (13%), 186 (48), 146 (14%) and 120 (15 %). 
5h IR ύ (cm
-1
): 3277, 3219 (NH2) 1652 (C=O); 1625 (C=N) and 1601 (C=C). 
6c IR ύ (cm
-1
): 3252 (NH); 1735, 1691 (CO's); 1629 (C=N) and 1609 (C=C). 
Mass (m/z):  251 (100.0%); 252 (15.0%) and 253 (1.2%). 
6d IR ύ (cm
-1
): 3295 (NH); 1721, 1677 (C=O's); 1612 (C=N) and 1601 (C=C). 
1
H NMR δH (ppm): 1.95 (m, 2H, CH2-aliph.); 2.23 (t, 4H, 2 CH2-aliph); 3.91 (s, 3H, CH3) 
7.11-7.80 (m, 4H, ArH's) 8.10 (s, 1H, NH) and 10.08 (s, 1H, COOH). 
7e 
1
H NMR δH (ppm): 1.90 (d, 2H, NH2); 2.03 (m, 1H, NHC=S); 2.48-2.53 (t, 4H, 2CH2) 8.10 
(d, 1H, NHC=O) and 10.07 (s, 1H, COOH). 
9a 
1
H NMR δH (ppm): 1.80-2.40 (m, 4H, 2CH2); 4.30 (m, 4H, 2NH2); 7.52-7.88 (m, 4H, ArH's) 
and 7.91 (m, 1H, NH). 
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